Gollob Jared (CIK 0001821198)

Latest company ownership

Role: Chief Medical Officer
Shares held
22,210
Last filed at
Oct 15, 2025
Confidence Score
13.0
2025Q4
Confidence Score History
2021Q1 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Dec 8, 2025 Dec 8, 2025 Kymera Therapeutics, Inc. Chief Medical Officer Sell 5.0 -49,307 -30.95% $4.4M
Oct 15, 2025 Oct 15, 2025 Kymera Therapeutics, Inc. Chief Medical Officer Sell 5.0 -59,576 -35.13% $3.7M
Oct 13, 2025 Oct 14, 2025 Kymera Therapeutics, Inc. Chief Medical Officer Sell 41.3 -3,114 -2.56% $186.8K
Mar 3, 2025 Mar 3, 2025 Kymera Therapeutics, Inc. Chief Medical Officer Sell 95.0 +24,260 25.34% $174.8K
Jul 15, 2024 Jul 16, 2024 Kymera Therapeutics, Inc. Chief Medical Officer Sell 20.0 -39,600 -11.77% $1.8M
Mar 1, 2024 Mar 4, 2024 Kymera Therapeutics, Inc. Chief Medical Officer Sell 95.0 +21,031 28.15% $140K
Feb 27, 2024 Feb 29, 2024 Kymera Therapeutics, Inc. Chief Medical Officer Sell 51.3 -400 -0.53% $18K
Feb 9, 2024 Feb 9, 2024 Kymera Therapeutics, Inc. Chief Medical Officer Sell 5.0 -46,137 -38.18% $1.6M
Mar 1, 2023 Mar 3, 2023 Kymera Therapeutics, Inc. Chief Medical Officer Sell 91.3 +17,452 30.48% $40.2K
Nov 1, 2021 Nov 2, 2021 Kymera Therapeutics, Inc. Chief Medical Officer Sell 15.0 -57,493 -19.36% $3.6M
Mar 11, 2021 Mar 15, 2021 Kymera Therapeutics, Inc. Chief Medical Officer Sell 22.5 -15,000 -14.62% $902K
Feb 22, 2021 Feb 24, 2021 Kymera Therapeutics, Inc. Chief Medical Officer Sell 5.0 -37,064 -43.81% $1.9M
Feb 17, 2021 Feb 19, 2021 Kymera Therapeutics, Inc. Chief Medical Officer Sell 10.0 -22,936 -21.33% $1.3M